{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:21:04Z","timestamp":1769692864763,"version":"3.49.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":365,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gunnar Nilsson Foundations"},{"DOI":"10.13039\/501100005753","name":"Royal Physiographic Society in Lund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003748","name":"Swedish Society for Medical Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Hepatic fibrosis is considered as a physiological wound-healing response to liver injury. The process involves several factors, such as hepatocyte growth factor (HGF), which restrains hepatic injury and facilitates reversibility of fibrotic reaction in response to an acute insult. Chronic liver injury and sustained inflammation cause progressive fibrosis and, ultimately, organ dysfunction. The mechanisms tipping the balance from restoration to progressive liver tissue scarring are not well understood. In the present study, we identify a mechanism in which the tumor-suppressor gene, <jats:italic toggle=\"yes\">cylindromatosis<\/jats:italic> (CYLD), confers protection from hepatocellular injury and fibrosis. Mice lacking CYLD (CYLD<jats:sup>\u2212\/\u2212<\/jats:sup>) were highly susceptible to hepatocellular damage, inflammation, and fibrosis and revealed significantly lower hepatic HGF levels, compared to wild-type (WT) animals. Exogenous application of HGF rescued the liver injury phenotype of CYLD<jats:sup>\u2212\/\u2212<\/jats:sup> mice. In the absence of CYLD, gene transcription of HGF in hepatic stellate cells was repressed through binding of histone deacetylase 7 (HDAC7) to the promoter of HGF. In WT cells, CYLD removed HDAC7 from the HGF promoter and induced HGF expression. Of note, this interaction occurred independently of the deubiquitinating activity of CYLD. <jats:italic toggle=\"yes\">Conclusions<\/jats:italic>: Our findings highlight a novel link between CYLD and HDAC7, offering mechanistic insight into the contribution of these proteins to progression of liver disease. Thus, through regulation of HGF level, CYLD ameliorates hepatocellular damage and liver fibrogenesis. (Hepatology 2014;60:1066\u20131081)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.27209","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T06:36:52Z","timestamp":1399617412000},"page":"1066-1081","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":36,"title":["Cylindromatosis gene CYLD regulates hepatocyte growth factor expression in hepatic stellate cells through interaction with histone deacetylase 7"],"prefix":"10.1097","volume":"60","author":[{"given":"Rajeswara R.","family":"Pannem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Hellerbrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Massoumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-33-20250207","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis.","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"R3-33-20250207","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis.","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"R4-33-20250207","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2217\/fon.10.187","article-title":"CYLD: a deubiquitination enzyme with multiple roles in cancer.","volume":"7","author":"Massoumi","year":"2011","journal-title":"Future Oncol"},{"key":"R5-33-20250207","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00018-007-7465-4","article-title":"Tumor suppressor CYLD: negative regulation of NFkappaB signaling and more.","volume":"65","author":"Courtois","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"R6-33-20250207","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/cdd.2009.43","article-title":"CYLD: a tumor suppressor deubiquitinase regulating NFkappaB activation and diverse biological processes.","volume":"17","author":"Sun","year":"2010","journal-title":"Cell Death Differ"},{"key":"R7-33-20250207","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.tibs.2010.02.007","article-title":"Ubiquitin chain cleavage: CYLD at work.","volume":"35","author":"Massoumi","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"R8-33-20250207","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/carcin\/bgl081","article-title":"Reduced expression of CYLD in human colon and hepatocellular carcinomas.","volume":"28","author":"Hellerbrand","year":"2007","journal-title":"Carcinogenesis"},{"key":"R9-33-20250207","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4161\/cbt.5.6.2662","article-title":"Adenoviral vector expressing CYLD augments antitumor activity of TRAIL by suppression of NFkappaB survival signaling in hepatocellular carcinoma.","volume":"5","author":"Chu","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"R10-33-20250207","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ccr.2012.04.026","article-title":"Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer.","volume":"21","author":"Nikolaou","year":"2012","journal-title":"Cancer Cell"},{"key":"R11-33-20250207","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jhep.2012.06.017","article-title":"Liver specific deletion of CYLDexon78 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice.","volume":"57","author":"Urbanik","year":"2012","journal-title":"J Hepatol"},{"key":"R12-33-20250207","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrm2145","article-title":"Histone acetyltransferase complexes: one size doesnt fit all.","volume":"8","author":"Lee","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R13-33-20250207","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R14-33-20250207","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10456-012-9279-8","article-title":"The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells.","volume":"15","author":"Turtoi","year":"2012","journal-title":"Angiogenesis"},{"key":"R15-33-20250207","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/me.2012-1302","article-title":"HDAC7 inhibits osteoclastogenesis by reversing RANKLtriggered betacatenin switch.","volume":"27","author":"Jin","year":"2013","journal-title":"Mol Endocrinol"},{"key":"R16-33-20250207","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1074\/jbc.M110.146860","article-title":"Neuroprotection by histone deacetylase7 (HDAC7) occurs by inhibition of cjun expression through a deacetylaseindependent mechanism.","volume":"286","author":"Ma","year":"2011","journal-title":"J Biol Chem"},{"key":"R17-33-20250207","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/MCB.00907-09","article-title":"Histone deacetylase 7 and FoxA1 in estrogenmediated repression of RPRM.","volume":"30","author":"Malik","year":"2010","journal-title":"Mol Cell Biol"},{"key":"R18-33-20250207","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ni.2008","article-title":"Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes.","volume":"12","author":"Navarro","year":"2011","journal-title":"Nat Immunol"},{"key":"R19-33-20250207","first-page":"239","article-title":"Trichostatin A, lead compound for development of antifibrogenic drugs.","volume":"64","author":"Rombouts","year":"2001","journal-title":"Acta Gastroenterol Belg"},{"key":"R20-33-20250207","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.510290328","article-title":"A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.","volume":"29","author":"Niki","year":"1999","journal-title":"Hepatology"},{"key":"R21-33-20250207","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0168-8278(02)00275-1","article-title":"Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor.","volume":"37","author":"Rombouts","year":"2002","journal-title":"J Hepatol"},{"key":"R22-33-20250207","doi-asserted-by":"crossref","first-page":"15225","DOI":"10.1074\/jbc.M212639200","article-title":"Specific expression and regulation of the new melanoma inhibitory activityrelated gene MIA2 in hepatocytes.","volume":"278","author":"Bosserhoff","year":"2003","journal-title":"J Biol Chem"},{"key":"R23-33-20250207","first-page":"G269","article-title":"Cytokines induce NFkappaB in activated but not in quiescent rat hepatic stellate cells.","volume":"275","author":"Hellerbrand","year":"1998","journal-title":"Am J Physiol"},{"key":"R24-33-20250207","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbrc.2004.10.020","article-title":"LPSmediated NFkappaB activation varies between activated human hepatic stellate cells from different donors.","volume":"325","author":"Muhlbauer","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R25-33-20250207","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2006.03.041","article-title":"Cyld inhibits tumor cell proliferation by blocking Bcl3dependent NFkappaB signaling.","volume":"125","author":"Massoumi","year":"2006","journal-title":"Cell"},{"key":"R26-33-20250207","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbrc.2008.10.155","article-title":"TNFalpha is required for cholestasisinduced liver fibrosis in the mouse.","volume":"378","author":"Gabele","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl 1","key":"R27-33-20250207","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1440-1746.2010.06549.x","article-title":"Hepatocyte growth factor twenty years on: Much more than a growth factor.","volume":"26","author":"Nakamura","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R28-33-20250207","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.gastro.2008.01.014","article-title":"Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin7.","volume":"134","author":"Inagaki","year":"2008","journal-title":"Gastroenterology"},{"key":"R29-33-20250207","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12072-007-9042-1","article-title":"Adenoassociated virus vectormediated production of hepatocyte growth factor attenuates liver fibrosis in mice.","volume":"2","author":"Suzumura","year":"2008","journal-title":"Hepatol Int"},{"key":"R30-33-20250207","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1478-3231.2005.01098.x","article-title":"Treatment of experimental hepatic fibrosis by combinational delivery of urokinasetype plasminogen activator and hepatocyte growth factor genes.","volume":"25","author":"Lin","year":"2005","journal-title":"Liver Int"},{"key":"R31-33-20250207","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/hep.20138","article-title":"Hepatocyte growth factor induces Mcl1 in primary human hepatocytes and inhibits CD95mediated apoptosis via Akt.","volume":"39","author":"SchulzeBergkamen","year":"2004","journal-title":"Hepatology"},{"key":"R32-33-20250207","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1242\/dev.02820","article-title":"Met acts on Mdm2 via mTOR to signal cell survival during development.","volume":"134","author":"Moumen","year":"2007","journal-title":"Development"},{"key":"R33-33-20250207","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/hep.21604","article-title":"Met signals hepatocyte survival by preventing Fastriggered FLIP degradation in a PI3kAktdependent manner.","volume":"45","author":"Moumen","year":"2007","journal-title":"Hepatology"},{"key":"R34-33-20250207","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00534-010-0304-2","article-title":"Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases.","volume":"18","author":"Fujiyoshi","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R35-33-20250207","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1034\/j.1600-0676.2003.00827.x","article-title":"Triiodothyronine and interleukin6 (IL6) induce expression of HGF in an immortalized rat hepatic stellate cell line.","volume":"23","author":"Kariv","year":"2003","journal-title":"Liver Int"},{"key":"R36-33-20250207","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbrc.2007.11.089","article-title":"Inhibition of tumorstromal interaction through HGFMet signaling by valproic acid.","volume":"366","author":"Matsumoto","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R37-33-20250207","doi-asserted-by":"crossref","first-page":"47496","DOI":"10.1074\/jbc.M107631200","article-title":"Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7.","volume":"276","author":"Kao","year":"2001","journal-title":"J Biol Chem"},{"key":"R38-33-20250207","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1091\/mbc.e07-11-1203","article-title":"Signaldependent regulation of transcription by histone deacetylase 7 involves recruitment to promyelocytic leukemia protein nuclear bodies.","volume":"19","author":"Gao","year":"2008","journal-title":"Mol Biol Cell"},{"key":"R39-33-20250207","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/carcin\/bgt335","article-title":"CYLD controls cMYC expression through the JNKdependent signaling pathway in hepatocellular carcinoma.","volume":"35","author":"Pannem","year":"2014","journal-title":"Carcinogenesis"},{"key":"R40-33-20250207","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/oxfordjournals.jbchem.a124958","article-title":"Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats.","volume":"118","author":"Matsuda","year":"1995","journal-title":"J Biochem"},{"key":"R41-33-20250207","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.510260111","article-title":"Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosiscirrhosis.","volume":"26","author":"Matsuda","year":"1997","journal-title":"Hepatology"},{"key":"R42-33-20250207","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/5593","article-title":"Hepatocyte growth factor gene therapy of liver cirrhosis in rats.","volume":"5","author":"Ueki","year":"1999","journal-title":"Nat Med"},{"key":"R43-33-20250207","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrm3012","article-title":"MET signalling: principles and functions in development, organ regeneration and cancer.","volume":"11","author":"Trusolino","year":"2010","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27209","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201409000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:17:14Z","timestamp":1738948634000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201409000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27209","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}